CERE (cerevel.com) Sof daromad

Cerevel Therapeutics Inc (CERE) kompaniyasining rasmiy ramzlari

Cerevel Therapeutics (CERE) ishlab chiqarish va sinovlar uchun autsorsingga tayanadi, bu esa uning moslashuvchan tadqiqot markazi sifatidagi maqomini saqlab qoladi. Ushbu grafikdagi kompaniyaning operatsion foydasi ushbu modelni tasdiqlaydi, bunda ko'rsatkich qiymati -0.46 ni tashkil etadi. Sog'liqni saqlash giganti AbbVie tomonidan premiumga sotib olinishi, shuningdek, shizofreniya va Parkinson kasalliklariga qarshi dori vositalarining muvaffaqiyati, tor klinik portfelning binar risklarini muvaffaqiyatli bartaraf etgan asosiy omillar bo'lib xizmat qildi.

Kompaniyaning sof foydasi: Cerevel Corp (CERE) 04.07.2022 - 10.08.2024 uchun

Cerevel Therapeutics, Inc. (CERE) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
Birja narxi Cerevel Corp|CERE - Tahlilchilar konsensus prognozi
- biznesning bozor baholash ko'rsatkichlari:
Bozor bahosi Cerevel Corp|CERE - Korxona qiymati
- kompaniyaning balans qiymati tafsilotlari:
Bitta aksiya hisobiga sof aktivlar qiymati Cerevel Therapeutics|CERE - Kompaniyaning balans qiymati|Balans qiymatiga nisbatan bozor qiymati cerevel.com|CERE - Kompaniyaning umumiy aktivlari
- qarz yuki va likvidlik ko'rsatkichlari:
Qarzning kapitalga nisbati Cerevel Therapeutics|CERE - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Cerevel Therapeutics Inc|CERE - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar Cerevel Corp|CERE - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzi Cerevel Therapeutics|Oraliq qoplash koeffitsiyenti cerevel.com
- kompaniyaning daromadliligi va baholash multiplikatorlari ko'rsatkichlari:
CERE - Sof daromad
Fundamental baholash:CERE Cerevel Corp
Cerevel Therapeutics Inc brend mahsuloti

Sof foyda barcha operatsion xarajatlar chegirib tashlanganidan keyin biznesning kapital yaratish bo'yicha yakuniy qobiliyatini aks ettiradi va bu bozor shovqinlarini fundamental tendentsiyadan ajratish imkonini beradi. Cerevel Therapeutics (CERE) kompaniyasining umumiy moliyaviy natijalarini tahlil qilish FDA ning qat'iy nazorati va markaziy nerv tizimi (CNS) buzilishlarini davolovchi mualliflik dori vositalarini ishlab chiqishning yuqori xarajatlari sharoitida kompaniyaning barqarorligini baholashga yordam beradi.

Asosiy raqobatchilar

Kompaniyaning sof daromadi Biogen Idec (BIIB)|NBIX (Neurocrine Biosciences) - Sof foyda|Sof daromad regencellbioscience.com (RGC)|Sof foyda AXSM|ACAD - Kompaniyaning sof daromadi|Kompaniyaning sof foydasi Xenon Pharmaceuticals Inc XENE|Yakuniy foyda VKTX|Supernus Pharmaceuticals - Sof foyda|Kompaniyaning sof daromadi catalystpharma.com|DNLI (Denali Therapeutics Inc.) - Sof daromad|HRMY (Harmony Biosciences Inc) - Kompaniyaning sof foydasi|BHVN (Biohaven Pharmaceutical) - Sof foyda|Kompaniyaning sof daromadi Amylyx Corp AMLX|Kompaniyaning sof foydasi Trevi Therapeutics (TRVI)|Kompaniyaning sof foydasi PRAX (praxismedicines.com)|Anavex Life Sciences Corp. - Sof daromad|Yakuniy foyda CBLL|PRTA: Sof daromad|Alector, Inc. - Soliqlar to‘langandan keyingi foyda|ANNX: Sof foyda|Omeros - Yakuniy foyda|NGNE (Neurogene) - Sof foyda|Kompaniyaning sof daromadi AC Immune S.A. ACIU|Kompaniyaning sof foydasi Voyager Pharma (VYGR)|NMRA (Neumora Corp) - Yakuniy foyda|Sof foyda SCLX (Scilex Holding Company)|Sof foyda tevogen.com TVGN|ACOG - Kompaniyaning sof foydasi|Soliqdan keyingi foyda CGTX|IKT: Sof foyda|Kompaniyaning sof daromadi Cassava Pharma (SAVA)|Sof daromad ASRT|Sof foyda Coya|Sof daromad VTGN (Vistagen Therapeutics)|Soliqlar to‘langandan keyingi foyda OVID|Sof foyda ABOS (Acumen Pharma)|Sof moliyaviy natija CervoMed Corporation (CRVO)|Alterity Therapeutics Ltd - Sof foyda|Clene Inc. (CLNN) - Sof daromad|pepgen.com (PEPG) - Kompaniyaning sof foydasi|JUNS - Sof moliyaviy natija|RLMD (Relmada) - Sof foyda|Sof daromad Annovis Bio Corporation (ANVS)|Sof foyda GRCE|AIFF - Kompaniyaning sof daromadi|Kompaniyaning sof foydasi Klotho Neurosciences KLTO|Yakuniy foyda NRSN|Reviva Pharmaceuticals Holdings - Sof foyda|Kompaniyaning sof daromadi MetaVia Inc|NeurAxis, Inc. (NRXS) - Kompaniyaning sof foydasi|Kompaniya foydasi HSDT|PASG (Passage Bio Inc.) - Sof foyda|Kompaniyaning sof daromadi Neuphoria NEUP|Sof daromad NERV (Minerva Neurosciences Corp)|Sof foyda Athira Pharma Corp (ATHA)|Kompaniyaning sof foydasi Addex Therapeutics ADXN|Yakuniy foyda ALZN|CYCN - Kompaniyaning sof foydasi|Kompaniyaning sof daromadi Protagenic Therapeutics|KTTA: Sof foyda|Sof daromad Cortigent|ATXI (Avenue Therapeutics) - Sof foyda|Kompaniyaning sof daromadi brainstorm-cell.com BCLI|Kompaniyaning sof foydasi Cara Therapeutics (CARA)|CHRO (Chromocell Therapeutics Corp) - Yakuniy foyda|Sof foyda ELYM (Eliem Therapeutics Inc.)|Intra-Cellular Therapies Inc. (ITCI) - Kompaniyaning sof daromadi|LBPH: Sof daromad|MRNS: Kompaniyaning sof foydasi|NKGN: Sof foyda|Kompaniyaning sof daromadi NeuroBo Pharmaceuticals Inc (NRBO)|Kompaniyaning sof foydasi Sage Therapeutics, Inc|Kompaniyaning sof foydasi SNPX|Sof daromad TRVN (Trevena, Inc.)|VIGL (vigilneuro.com) - Yakuniy foyda|Anew Medical, Inc. - Sof daromad